These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22595150)

  • 1. 1,25(OH)2D3 inhibits the deleterious effects induced by high glucose on osteoblasts through undercarboxylated osteocalcin and insulin signaling.
    Wu YY; Yu T; Zhang XH; Liu YS; Li F; Wang YY; Wang YY; Gong P
    J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):112-9. PubMed ID: 22595150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
    Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
    Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells.
    Inaba M; Terada M; Koyama H; Yoshida O; Ishimura E; Kawagishi T; Okuno Y; Nishizawa Y; Otani S; Morii H
    J Bone Miner Res; 1995 Jul; 10(7):1050-6. PubMed ID: 7484280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts.
    Koshihara Y; Hoshi K; Ishibashi H; Shiraki M
    Calcif Tissue Int; 1996 Dec; 59(6):466-73. PubMed ID: 8939773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.
    Gómez-García L; Esbrit P; Carreño L; Sabando P; García-Flores M; Martinez ME
    J Bone Miner Res; 2003 Jan; 18(1):78-87. PubMed ID: 12510808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
    Sterck JG; Klein-Nulend J; Burger EH; Lips P
    J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction effects between 1,25-dihydroxyvitamin D3 and transforming growth factor-beta1 on the proliferation and differentiation of human embryonic osteoblasts].
    Pei Y; Zhou XY; Meng XW; Xia WB; Xing XP; Liu HC; Hu YY
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1084-8. PubMed ID: 12899784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element.
    Uchida M; Ozono K; Pike JW
    J Bone Miner Res; 1994 Dec; 9(12):1981-7. PubMed ID: 7872065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine decreases vitamin D receptor protein expression and 1,25(OH)2D3 stimulated alkaline phosphatase activity in human osteoblast cells.
    Rapuri PB; Gallagher JC; Nawaz Z
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):368-71. PubMed ID: 17223552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro.
    Koshihara Y; Hoshi K
    J Bone Miner Res; 1997 Mar; 12(3):431-8. PubMed ID: 9076586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3.
    Lohmann CH; Bonewald LF; Sisk MA; Sylvia VL; Cochran DL; Dean DD; Boyan BD; Schwartz Z
    J Bone Miner Res; 2000 Jun; 15(6):1169-80. PubMed ID: 10841186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
    Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
    J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1α,25-Dihydroxyvitamin D
    Xiong Y; Zhang Y; Xin N; Yuan Y; Zhang Q; Gong P; Wu Y
    J Steroid Biochem Mol Biol; 2017 Nov; 174():153-160. PubMed ID: 28859991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in osteocalcin response to 1,25-dihydroxyvitamin D(3) stimulation and basal vitamin D receptor expression in human osteoblastic cells according to donor age and skeletal origin.
    Martínez P; Moreno I; De Miguel F; Vila V; Esbrit P; Martínez ME
    Bone; 2001 Jul; 29(1):35-41. PubMed ID: 11472889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The local production of 1,25(OH)2D3 promotes osteoblast and osteocyte maturation.
    Turner AG; Hanrath MA; Morris HA; Atkins GJ; Anderson PH
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():114-8. PubMed ID: 24125735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ investigation of vitamin D receptor, alkaline phosphatase, and osteocalcin gene expression in oro-facial mineralized tissues.
    Davideau JL; Papagerakis P; Hotton D; Lezot F; Berdal A
    Endocrinology; 1996 Aug; 137(8):3577-85. PubMed ID: 8754789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrocortisone and deflazacort induce different effects on vitamin D receptor level increase produced by 1,25-dihydroxyvitamin D3 in rat osteoblast-like UMR-106 cells.
    Guerrero R; de la Piedra C; Teixeiro E; Bragado R; Traba ML
    J Rheumatol; 2004 Jan; 31(1):167-72. PubMed ID: 14705237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VDR dependent and independent effects of 1,25-dihydroxyvitamin D3 on nitric oxide production by osteoblasts.
    Willems HM; van den Heuvel EG; Carmeliet G; Schaafsma A; Klein-Nulend J; Bakker AD
    Steroids; 2012 Jan; 77(1-2):126-31. PubMed ID: 22093484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable hormone responsiveness of osteoblast populations isolated at different stages of embryogenesis and its relationship to the osteogenic lineage.
    Gerstenfeld LC; Zurakowski D; Schaffer JL; Nichols DP; Toma CD; Broess M; Bruder SP; Caplan AI
    Endocrinology; 1996 Sep; 137(9):3957-68. PubMed ID: 8756572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine/paracrine action of vitamin D on FGF23 expression in cultured rat osteoblasts.
    Tang WJ; Wang LF; Xu XY; Zhou Y; Jin WF; Wang HF; Gao J
    Calcif Tissue Int; 2010 May; 86(5):404-10. PubMed ID: 20354682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.